- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD) in Australia
Total 1965 results
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
University Hospital of North NorwayUniversity of Tromso; The Research Council of Norway; The Alfred; Aalborg University and other collaboratorsCompletedPulmonary Disease, Chronic ObstructiveNorway, Denmark, Australia
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseFrance, Germany, Italy, Spain, United Kingdom, Austria, Hungary
-
Otto Wagner HospitalCompletedPulmonary Disease, Chronic ObstructiveAustria
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, Canada, New Zealand
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Austria, Canada, Germany, Greece, New Zealand, Norway, Slovakia, South Africa, Sweden
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseKorea, Republic of, Austria, Belgium, Germany, Greece, Russian Federation, Australia, Brazil, Canada, Denmark, France, Hungary, Israel, Italy, Netherlands, Poland, Slovakia, South Africa, Spain, Turkey, United Kingdom
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveAustralia, United Kingdom, Argentina, Germany, India
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Sweden, Australia, Hungary, Bulgaria, South Africa, Poland, Slovakia, India, Canada, Argentina, Czech Republic, Chile, New Zealand, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingChronic Obstructive Pulmonary Disease | Pulmonary HypertensionUnited States, Korea, Republic of, Australia, Germany, Spain, Italy, Switzerland, France, Argentina, Colombia, Israel, Austria, Mexico, United Kingdom, Belgium, Turkey, Peru, South Africa
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States, Spain, Switzerland, France, Italy, Germany, Turkey, Hungary, Norway, Slovakia, Poland, Russian Federation, Canada, Belgium, Austria, Colombia, Denmark, Finland, Greece, Israel, Mexico, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Germany, Canada, United States, Poland, Belgium, Portugal, United Kingdom, Australia, Denmark, New Zealand
-
AstraZenecaActive, not recruitingChronic Obstructive Pulmonary DiseaseUnited States, Austria, Canada, Denmark, Germany, Italy, Spain, United Kingdom, Belgium, Vietnam, Brazil, Hungary, Philippines, China, Korea, Republic of, Argentina, Australia, Poland, Turkey, Japan, Greece, Netherlands, Czechia, Mexico, Bulgar... and more
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, United States, Colombia, Poland, South Africa, Canada, Estonia, Hungary, India, Austria, Israel, Netherlands, United Kingdom, Argentina, France, Italy, Spain, Czech Republic, Denmark, Finland, Greece, Ireland, Mexico, Peru, Phi... and more
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, Canada, New Zealand
-
SanofiRegeneron PharmaceuticalsActive, not recruitingChronic Obstructive Pulmonary DiseaseGreece, Belgium, Spain, Argentina, Hungary, South Africa, United Kingdom, France, Latvia, Germany, Netherlands, Russian Federation, Ukraine, United States, Australia, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Lithuania, Me... and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Canada, Germany, Poland, Romania, Spain, United States, Korea, Republic of, Netherlands
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Argentina, Japan, Russian Federation, Spain, Germany, Mexico, Romania, Korea, Republic of, Poland, Italy, France
-
Chiesi Farmaceutici S.p.A.RecruitingChronic Obstructive Pulmonary DiseaseBulgaria, United States, Albania, Argentina, Australia, Austria, Bosnia and Herzegovina, Chile, China, Czechia, Georgia, Germany, Greece, Hungary, Israel, Italy, Mexico, Netherlands, New Zealand, North Macedonia, Poland, Romania, Russian... and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Czechia, Hungary, Israel, Romania, Russian Federation, Slovakia, Slovenia, Switzerland
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, Belgium, Colombia, Romania, South Africa, Italy, Hungary, Taiwan, Turkey, Switzerland, Australia, France, Israel, Sweden, China, Thailand, Estonia, Netherlands, Russian Federation, Slovakia, Spain, Argentina, Lithuania, Austria, Cana... and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Canada, Spain, United States, Finland, Italy, Russian Federation, United Kingdom, New Zealand, Australia, France, Greece, Ireland, Netherlands, South Africa
-
Chiesi Farmaceutici S.p.A.RecruitingChronic Obstructive Pulmonary DiseaseBulgaria, United States, Argentina, Austria, Bosnia and Herzegovina, Chile, Croatia, Czechia, Estonia, Germany, Greece, Hungary, Israel, Latvia, Mexico, Netherlands, New Zealand, North Macedonia, Poland, Romania, Russian Federation and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Germany, Italy, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
GlaxoSmithKlineTerminatedPulmonary Disease, Chronic ObstructiveAustralia, Argentina, France, Germany, Poland, Romania, Russian Federation, Spain, United States, Netherlands, Sweden, Korea, Republic of, Canada, United Kingdom, Italy, Mexico
-
Isabelle Opitz, Professor, MDRecruitingSurgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema (SINCERE)EmphysemaBelgium, Switzerland, Denmark, Austria
-
PfizerTerminatedPulmonary Disease, Chronic ObstructiveAustralia, Canada, Czech Republic, Croatia, Spain, Hungary, Argentina, Singapore, United Kingdom, Chile
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Germany, Estonia, Chile, Netherlands, Peru, South Africa, Sweden, Mexico, United Kingdom, Italy, Philippines, Canada
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, France, Romania, Finland, Taiwan, Bulgaria, Estonia, Canada, Netherlands, Philippines, South Africa, Sweden, Spain, Singapore, Austria, Germany, Latvia, New Zealand, China, Ukraine, Thailand, Greece, United Kingdom and more
-
Georg-Christian FunkUnknownPulmonary Disease, Chronic ObstructiveAustria
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Australia, United States, Germany, Chile, Korea, Republic of, Mexico, Canada, South Africa, Romania
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveDenmark, Austria, Finland, France, Slovenia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Argentina, Germany, Spain, South Africa, Mexico, Peru, Netherlands, Canada, United Kingdom, Denmark, Chile, Italy, Sweden
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructivePuerto Rico, United States, Australia, Argentina, France, Germany, Japan, Netherlands, Russian Federation, Spain, Ukraine, Finland, Czechia, Poland, Belgium, Chile, Peru, South Africa, Sweden, Thailand, Israel, Korea, Republic of, C... and more
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireTerminatedChronic Obstructive Pulmonary Disease | Alpha1-antitrypsin DeficiencyUnited States, Canada, Australia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany, Netherlands, Denmark, France, South Africa, Austria, Belgium, Sweden
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Canada, Germany, Spain, United States, Italy, Netherlands, South Africa, Sweden, France, Mexico, Australia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany, Canada, Spain, Russian Federation, United States, Belgium, France, Greece, Sweden, Norway, Turkey, Australia, Netherlands, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Canada, France, Poland, Russian Federation, Spain, Estonia, Belgium, Peru, Sweden, Greece, Mexico, Norway, Italy, Czechia
-
Boston Scientific CorporationPneumRx, Inc.CompletedEmphysemaUnited Kingdom, France, Germany, Netherlands, Italy, Austria
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, Belgium, Brazil, Bulgaria, China, Denmark, France, Germany, Greece, Hungary, Italy, Netherlands, New Zealand, Philippines, Poland, Russian Federation, South Africa, Spain, Taiwan, Tunisia, Turkey, Ukraine, United Kingdom
-
Novartis PharmaceuticalsCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Canada, Hungary, Japan, Czechia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, China, Germany, New Zealand, Taiwan
-
Gala Therapeutics, Inc.CompletedChronic BronchitisChile, Austria
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveCanada, Germany, United States, Australia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Bulgaria, Canada, China, Czech Republic, Denmark, Estonia, Finland, France, Germany, Guatemala, Hungary, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian... and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Belgium, Canada, Germany, Russian Federation